Breo Ellipta is a once-daily prescription inhaler used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains fluticasone furoate, a corticosteroid that reduces inflammation, and vilanterol, a long-acting bronchodilator that helps open the airways for easier breathing. Breo Ellipta is designed for long-term control and is not a rescue inhaler for sudden breathing problems.
- “Adlyxin (Lixisenatide Or Lyxumia)” already exists in your wishlist
Breo Ellipta
Roll over image to zoom in
$149.95 – $189.95
Breo Ellipta: Once‑Daily Dual‑Action Maintenance Inhaler for Asthma and COPD
Breo Ellipta is a prescription inhaler designed to deliver two powerful medications—fluticasone furoate and vilanterol—in a single, easy‑to‑use device. This once‑daily therapy offers both anti‑inflammatory and bronchodilatory effects, making it an ideal maintenance option for patients with asthma and chronic obstructive pulmonary disease (COPD).
Introduction
Living with asthma or COPD means balancing symptom control, convenience, and cost. Research shows that adherence to maintenance therapy dramatically improves outcomes, reducing exacerbations and hospitalizations. Yet up to 50% of patients struggle with complicated dosing regimens or device misuse. Breo Ellipta addresses these challenges head‑on: its once‑daily dosing simplifies treatment, while the Ellipta device’s intuitive design minimizes errors.
At Fit Life Pharmacy, we understand that clear, patient‑focused information is key to effective therapy. Whether you’re newly diagnosed, recently switched inhalers, or simply seeking the cheapest Breo Ellipta inhaler options, our goal is to empower you with knowledge. Here, you’ll learn about the mechanism of action behind fluticasone furoate vilanterol inhaler therapy, detailed Breo Ellipta benefits for asthma and COPD management, potential side effects, comparisons with other inhalers like Advair, and practical tips for finding savings on your inhaler.
What Is Breo Ellipta?
Breo Ellipta combines two active ingredients in one dry powder inhaler:
- Fluticasone furoate (100 or 200 micrograms per dose): A potent inhaled corticosteroid that combats airway inflammation—the underlying cause of asthma symptoms and COPD exacerbations.
- Vilanterol (25 micrograms per dose): A long‑acting beta2‑agonist (LABA) that relaxes smooth muscle in the airways, helping them stay open for easier breathing.
Indications
- Asthma: Maintenance treatment in patients aged 5 years and older whose asthma is not adequately controlled with an inhaled corticosteroid alone.
- COPD (including chronic bronchitis and emphysema): Maintenance therapy to prevent exacerbations and improve lung function.
Device Design
The Ellipta inhaler features a pre‑loaded blister strip containing 30 doses. The slide‑and‑click mechanism readies one dose at a time, eliminating the need for priming, shaking, or assembly. A built‑in dose counter displays the remaining doses, so you’ll know exactly when it’s time for a refill.
By integrating both medications in a single, once‑daily inhaler, Breo Ellipta streamlines therapy—encouraging adherence and consistent control of respiratory symptoms.
Mechanism of Action
Understanding how Breo Ellipta works begins with its two complementary components:
Anti‑Inflammatory Action: Fluticasone Furoate
- Target: Reduces inflammation in the bronchial tubes by inhibiting multiple inflammatory cells and cytokines.
- Effect: Decreases airway swelling, mucus production, and hyperresponsiveness.
- Outcome: Fewer asthma attacks, less coughing, and reduced COPD exacerbations.
Fluticasone furoate’s high receptor affinity allows once‑daily dosing, providing sustained anti‑inflammatory effects throughout a 24‑hour period. This consistency is crucial for patients seeking long‑term symptom control.
Bronchodilatory Action: Vilanterol
- Target: Stimulates beta2‑adrenergic receptors on smooth muscle cells lining the airways.
- Effect: Activates cyclic AMP, leading to muscle relaxation and airway dilation.
- Outcome: Improved airflow, decreased shortness of breath, and enhanced exercise tolerance.
Vilanterol’s long half‑life supports sustained bronchodilation, so one inhalation each morning can keep airways open all day and into the night.
Synergistic Benefits
Combining fluticasone furoate and vilanterol in one inhaler offers advantages over monotherapy or separate devices:
- Enhanced symptom control: Tackles both inflammation and bronchoconstriction simultaneously.
- Reduced flare‑ups: Clinical trials show lower rates of asthma exacerbations and COPD hospitalizations compared to corticosteroid or LABA alone.
- Improved lung function metrics: Greater increases in forced expiratory volume in one second (FEV₁) vs monotherapy.
- Once‑daily convenience: Boosts adherence and simplifies treatment.
Clinical Efficacy and Benefits
Asthma Management
In randomized controlled trials, patients aged 12 years and older achieved significant improvements in lung function and symptom scores:
- Peak Expiratory Flow (PEF) increased by an average of 40–60 liters per minute over placebo.
- Exacerbation reduction: Up to 30% fewer asthma attacks requiring systemic steroids.
- Quality of life: Patients reported better sleep, fewer rescue inhaler uses, and greater overall well‑being.
Pediatric studies in children aged 5–11 also demonstrate enhanced control, making Breo Ellipta a versatile option across age groups.
COPD Management
For COPD patients, adding Breo Ellipta to long‑term care achieved:
- FEV₁ improvements of 0.10–0.13 liters vs vilanterol alone.
- Moderate/severe exacerbation reduction by up to 15%.
- Symptom relief: Lower daily dyspnea scores and decreased need for rescue medications.
Long‑term safety data over one year indicate stable efficacy and acceptable tolerability, confirming Breo Ellipta’s role in ongoing COPD management.
Health‑Economic Impact
By reducing exacerbations, Breo Ellipta can lower direct and indirect healthcare costs:
- Fewer hospital admissions and emergency visits.
- Decreased work or school absenteeism.
- Improved productivity and activity tolerance.
Patients earn additional benefits from cost‑saving measures such as Breo Ellipta coupon programs and exploring generic fluticasone furoate vilanterol inhaler options when available.
Usage and Dosage Guidelines
How to Use Breo Ellipta Inhaler
Mastering proper technique maximizes the inhaler’s effectiveness. Follow these steps each time you use Breo Ellipta:
- Open the cover: Hold the inhaler upright and slide the mouthpiece cover down until it clicks. A dose is now loaded.
- Exhale fully: Breathe out gently, away from the mouthpiece, to empty your lungs of air.
- Inhale the dose: Place the mouthpiece between your lips, forming a tight seal. Inhale steadily and deeply through your mouth. You may not taste or feel the powder, but the medication has entered your lungs.
- Hold your breath: Remove the inhaler from your mouth and hold your breath for 3–4 seconds or as long as comfortable.
- Close the device: Slide the mouthpiece cover back up until it clicks. If you need a second inhalation (only as prescribed), repeat steps 1–4.
Tip: Rinse your mouth and gargle with water after inhalation to reduce the risk of oral thrush.
Breo Ellipta Dosage Schedule
- Asthma (≥12 years): One inhalation of 100/25 mcg once daily in the morning.
- COPD: One inhalation of 100/25 mcg or 200/25 mcg once daily, depending on disease severity and physician recommendation.
Never exceed the prescribed dose, and take your inhaler around the same time each day to maintain consistent blood levels. If you miss a dose, take it as soon as you remember—unless your next dose is due within 12 hours. Do not double up on doses.
Side Effects and Safety Profile
Being aware of potential Breo Ellipta side effects empowers you to spot and address concerns early. While the majority of patients tolerate the inhaler well, some experience adverse reactions.
Common Side Effects
- Headache: Mild to moderate, often transient.
- Throat irritation or cough: Typically occurs soon after inhalation.
- Nasopharyngitis: Symptoms of a common cold, such as runny nose and sneezing.
- Oral thrush: A fungal infection in the mouth; mitigated by rinsing after use.
Less Common but Serious Side Effects
- Pneumonia: Higher risk in COPD patients; report symptoms like increased cough, fever, or chest pain.
- Cardiovascular effects: Palpitations, increased heart rate, or arrhythmias—patients with existing heart disease should be monitored closely.
- Adrenal suppression: Signs include fatigue, weight loss, or low blood pressure; rare but possible with long‑term corticosteroid exposure.
- Bone density reduction: Long‑term inhaled corticosteroid use may affect bone health; ensure adequate calcium and vitamin D intake.
Safety Considerations
- Drug Interactions: Ketoconazole and other CYP3A4 inhibitors can raise systemic corticosteroid levels; discuss all medications and supplements with your provider.
- Contraindications: Primary treatment of status asthmaticus or acute COPD exacerbations; use a short‑acting bronchodilator for rescue.
- Pregnancy & Lactation: Only if benefits outweigh risks; consult your healthcare professional.
Regular check‑ups and pulmonary function tests will help your clinician monitor your response and adjust dosing if necessary.
Comparison: Breo Ellipta vs. Other Inhalers
Choosing the right inhaler involves weighing convenience, efficacy, side-effect profile, and cost. Here’s how Breo Ellipta stacks up in popular comparisons:
Breo Ellipta vs. Advair
- Dosing Frequency: Once daily (Breo Ellipta) vs twice daily (Advair Diskus).
- Clinical Efficacy: Similar improvements in FEV₁ and exacerbation rates, with Breo often showing slightly fewer night‑time awakenings.
- Device Usability: Ellipta’s slide‑and‑click design is more intuitive than Advair’s lever and mouthpiece assembly.
- Preference: Many patients switch from Advair to Breo for the convenience of once‑daily dosing and simplified technique.
Breo Ellipta vs. Symbicort
- Components: Fluticasone furoate/vilanterol vs budesonide/formoterol.
- Onset of Action: Symbicort’s formoterol may act faster, but Breo provides stable 24‑hour coverage.
- Side Effects: Some reports suggest less throat irritation and hoarseness with fluticasone furoate-based inhalers.
- Adherence: Once‑daily dosing often leads to higher adherence compared to twice‑daily regimens.
Breo Ellipta vs. Trelegy Ellipta
- Triple Therapy: Trelegy adds umeclidinium (a long‑acting muscarinic antagonist) for triple action, beneficial in advanced COPD.
- Indication: Trelegy is reserved for patients needing additional bronchodilation; Breo remains first‑line for moderate cases.
- Cost Considerations: Breo typically has lower copays and more coupon programs available, making it more accessible for many patients.
When discussing “Breo Ellipta vs Advair” or “Breo Ellipta benefits for asthma,” consider your personal lifestyle, symptom patterns, and budget—then consult your healthcare provider for a tailored recommendation.
Tips for Finding the Best Price
Managing chronic respiratory disease can be expensive, but several strategies can help you secure the cheapest Breo Ellipta inhaler without compromising care:
- Manufacturer Savings Programs
- Visit the official Breo Ellipta website to download and print manufacturer coupons or savings cards.
- Eligible patients may pay as little as $0–$25 per month, depending on insurance status and household income.
- Pharmacy Discount Cards
- Services like GoodRx or SingleCare aggregate pharmacy pricing and offer instant rebates.
- Compare local retail, mail‑order, and big‑box pharmacy prices to find the best rates.
- Generic Alternatives
- Although generic fluticasone furoate vilanterol inhalers are relatively new, they often cost 30–50% less than the branded product.
- Ask your prescriber if a generic equivalent is appropriate for your treatment.
- Mail‑Order Pharmacies
- Ordering a 90‑day supply can reduce per‑dose cost and shipping fees.
- Many insurance plans incentivize mail‑order through lower copays.
- Assistance Programs
- Non‑profit organizations and patient advocacy groups sometimes offer grants or vouchers for those who qualify.
- Your pharmacist can help you identify local or national resources.
By combining these approaches, it’s possible to bring down your monthly out‑of‑pocket costs substantially—ensuring you never have to choose between breathing well and paying your bills.
Frequently Asked Questions
Q: How quickly does Breo Ellipta start working?
A: Many patients notice improved breathing within 24 hours of the first dose. However, maximum benefit is usually seen after 1–2 weeks of consistent daily use. Always continue therapy even if you feel better.
Q: Can I use Breo Ellipta as a rescue inhaler?
A: No. Breo Ellipta is a maintenance therapy and is not suitable for acute bronchospasm. Always carry a short‑acting bronchodilator (e.g., albuterol) for rescue use.
Q: What should I do if I miss a dose?
A: Take your missed dose as soon as you remember, unless it’s within 12 hours of your next scheduled dose. Do not double up on inhalations to make up for missed doses.
Q: Are there lifestyle changes that help with asthma and COPD management?
A: Yes—avoid triggers such as tobacco smoke, allergens, and air pollutants; maintain a healthy weight; follow a balanced diet rich in antioxidants; and engage in regular, doctor‑approved exercise to strengthen respiratory muscles.
Q: Can my child use Breo Ellipta?
A: Breo Ellipta is approved for asthma management in children aged 5 years and older. It is not indicated for COPD in pediatric patients.
Q: How should I store my inhaler?
A: Store at room temperature (15–30 °C), away from moisture and direct sunlight. Do not refrigerate or freeze. Keep the cover closed when not in use.
Q: How do I know when my inhaler is empty?
A: The built‑in dose counter will display “0.” Discard the inhaler once it hits zero, even if you still feel powder inside.
Q: Does Breo Ellipta interact with other medications?
A: Potent CYP3A4 inhibitors like ketoconazole can increase systemic corticosteroid levels. Inform your healthcare provider of all concurrent medications, including over‑the‑counter drugs and supplements.
Q: What precautions should I take during surgery?
A: Inform your anesthesiologist that you use inhaled corticosteroids. Adrenal suppression is possible, and you may require supplemental corticosteroids before major surgery.
Conclusion
Breo Ellipta’s combination of once‑daily convenience, dual‑action therapy, and a user‑friendly inhaler design makes it a leading choice for maintenance treatment of both asthma and COPD. Understanding how to use Breo Ellipta inhaler correctly, adhering to your personalized Breo Ellipta dosage schedule, and staying vigilant about potential Breo Ellipta side effects will help you achieve optimal control of your respiratory condition.
Whether you’re comparing Breo Ellipta vs Advair or evaluating the Breo Ellipta benefits for asthma and COPD management, this inhaler’s proven efficacy and favorable safety profile speak for themselves. To make therapy more affordable, explore Breo Ellipta coupon programs, pharmacy discount cards, and generic fluticasone furoate vilanterol inhaler options.
Ready to breathe easier? Discuss with your healthcare provider whether Breo Ellipta is the right maintenance therapy for you, and visit Fit Life Pharmacy for personalized support, savings opportunities, and expert guidance on managing your respiratory health.
You can also explore a wide range of diabetes-related products and weight loss solutions like Mounjaro, Ozempic and more at Fit Life Pharmacy for all your health and wellness needs. Whether you’re looking for additional monitoring tools, supplements, or support for weight management, we offer top-quality products designed to enhance your lifestyle and health. Visit us today to find everything you need to stay on track with your health goals!
Additional information
| Weight | 100mcg/25mcg, 200mcg/25mcg |
|---|---|
| Doses | 30 doses |
Reviews
There are no reviews yet.